Literature DB >> 21499536

CD34 Antigen: Determination of Specific Sites of Phosphorylation In Vitro and In Vivo.

Leesa J Deterding1, Jason G Williams, Margaret M Humble, Robert M Petrovich, Sung-Jen Wei, Carol S Trempus, Matthew B Gates, Feng Zhu, Robert C Smart, Raymond W Tennant, Kenneth B Tomer.   

Abstract

pan class="Gene">CD34, a type I transmembrane glycoprotein, is a surface antigen which is expressed on several cell types, including hematopoietic progenitors, endothelial cells, as well as mast cells. Recently, CD34 has been described as a marker for epidermal stem cells in mouse hair follicles, and is expressed in outer root sheath cells of the human hair follicle. Although the biological function and regulation of CD34 is not well understood, it is thought to be involved in cell adhesion as well as possibly having a role in signal transduction. In addition, CD34 was shown to be critical for skin tumor development in mice, although the exact mechanism remains unknown.Many proteins' functions and biological activities are regulated through post-translational modifications. The extracellular domain of CD34 is heavily glycosylated but the role of these glycans in CD34 function is unknown. Additionally, two sites of tyrosine phosphorylation have been reported on human CD34 and it is known that CD34 is phosphorylated, at least in part, by protein kinase C; however, the precise location of the sites of phosphorylation has not been reported. In an effort to identify specific phosphorylation sites in CD34 and delineate the possible role of protein kinase C, we undertook the identification of the in vitro sites of phosphorylation on the intracellular domain of mouse CD34 (aa 309-382) following PKC treatment. For this work, we are using a combination of enzymatic proteolysis and peptide sequencing by mass spectrometry. After which the in vivo sites of phosphorylation of full-length mouse CD34 expressed from HEK293F cells were determined. The observed in vivo sites of phosphorylation, however, are not consensus PKC sites, but our data indicate that one of these sites may possibly be phosphorylated by AKT2. These results suggest that other kinases, as well as PKC, may have important signaling functions in CD34.

Entities:  

Year:  2011        PMID: 21499536      PMCID: PMC3077033          DOI: 10.1016/j.ijms.2010.05.027

Source DB:  PubMed          Journal:  Int J Mass Spectrom        ISSN: 1387-3806            Impact factor:   1.986


  30 in total

1.  The adapter protein CrkL associates with CD34.

Authors:  D M Felschow; M L McVeigh; G T Hoehn; C I Civin; M J Fackler
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

Review 2.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

3.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

Authors:  John Rush; Albrecht Moritz; Kimberly A Lee; Ailan Guo; Valerie L Goss; Erik J Spek; Hui Zhang; Xiang-Ming Zha; Roberto D Polakiewicz; Michael J Comb
Journal:  Nat Biotechnol       Date:  2004-12-12       Impact factor: 54.908

4.  Fragmentation of phosphopeptides in an ion trap mass spectrometer.

Authors:  J P DeGnore; J Qin
Journal:  J Am Soc Mass Spectrom       Date:  1998-11       Impact factor: 3.109

Review 5.  CD34: structure, biology, and clinical utility.

Authors:  D S Krause; M J Fackler; C I Civin; W S May
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

6.  Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements.

Authors:  J R Woodgett; K L Gould; T Hunter
Journal:  Eur J Biochem       Date:  1986-11-17

7.  Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34.

Authors:  Carol S Trempus; Rebecca J Morris; Carl D Bortner; George Cotsarelis; Randall S Faircloth; Jeffrey M Reece; Raymond W Tennant
Journal:  J Invest Dermatol       Date:  2003-04       Impact factor: 8.551

8.  Selective zirconium dioxide-based enrichment of phosphorylated peptides for mass spectrometric analysis.

Authors:  Hye Kyong Kweon; Kristina Håkansson
Journal:  Anal Chem       Date:  2006-03-15       Impact factor: 6.986

9.  CD34 expression by hair follicle stem cells is required for skin tumor development in mice.

Authors:  Carol S Trempus; Rebecca J Morris; Matthew Ehinger; Amy Elmore; Carl D Bortner; Mayumi Ito; George Cotsarelis; Joanne G W Nijhof; John Peckham; Norris Flagler; Grace Kissling; Margaret M Humble; Leon C King; Linda D Adams; Dhimant Desai; Shantu Amin; Raymond W Tennant
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

10.  GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy.

Authors:  Yu Xue; Jian Ren; Xinjiao Gao; Changjiang Jin; Longping Wen; Xuebiao Yao
Journal:  Mol Cell Proteomics       Date:  2008-05-06       Impact factor: 5.911

View more
  1 in total

1.  Large Scale Generation and Characterization of Anti-Human CD34 Monoclonal Antibody in Ascetic Fluid of Balb/c Mice.

Authors:  Leili Aghebati Maleki; Jafar Majidi; Behzad Baradaran; Jalal Abdolalizadeh; Tohid Kazemi; Ali Aghebati Maleki; Koushan Sineh Sepehr
Journal:  Adv Pharm Bull       Date:  2013-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.